Another AI card! Lepu medical AI ECG analysis software approved

Author: Zhao Hongwei On February 7, 2020, the arterial network (wechat: vcpeat) learned that the ai-ecgplatform, a wholly-owned subsidiary of AI business unit of Lepu (Beijing) Medical Devices Co., Ltd (hereinafter referred to as "Lepu medical"), which was independently developed by Shenzhen Kewal Electronic Co., Ltd (hereinafter referred to as "the ai-ecgplatform"), was awarded by the State Drug Administration (hereinafter referred to as "nmpa") Registration approval It is reported that the product was registered and approved by the US Food and Drug Administration (hereinafter referred to as "FDA") in November 2018, and passed the EU CE registration and certification in November 2019 Ai-ecgplatform is the first AI ECG product approved and registered in China It is also the only AI ECG product approved by nmpa, FDA and CE at the same time This is the approval of another three types of instruments related to artificial intelligence after the "coronary flow reserve score software" of Keya medical Cardiovascular disease is the first killer of human health According to the China cardio cerebrovascular report 2017 released by the national cardio cerebrovascular disease center, there are 290 million patients with cardio cerebrovascular disease in China, which means that there is one cardio cerebrovascular disease patient in every five people around us Since 1990, the mortality rate of cardiovascular and cerebrovascular diseases in urban and rural areas in China has been increasing, reaching 50% basically ECG is the most simple, fast and economic clinical examination method for various cardiovascular diseases, and it is the cornerstone of cardiovascular disease examination Ai-ecgplatform is based on AI deep learning technology It uses tens of millions of ECG clinical big data for training Through automatic analysis of ECG events such as arrhythmia, myocardial infarction, ventricular hypertrophy and ST-T abnormality, the overall accuracy rate has reached more than 95%, realizing fast and accurate diagnosis of static ECG, and supporting the hospital The construction of ECG network inside and outside the hospital can effectively improve the informatization and intelligence level of the hospital Based on this technology platform, Lepu medical has developed a number of equipment such as AI chip electrostatic plotter, which provides a full process solution covering pre hospital screening, in-hospital inspection and monitoring, and post hospital rehabilitation monitoring, to assist in the construction of electrocardiographic information at home and abroad, and improve the efficiency and service level of electrocardiographic diagnosis and treatment Previously, Lepu medical said in the announcement that "ai-ecgplatform" will be widely used in four fields in the future, leading the revolution of ECG industry: 1 A large number of basic hospitals, individual clinics, physical examination centers, social health centers, elderly care institutions, etc lack of professional ECG doctors The application of this product will form an integrated technical service chain to realize localized and rapid ECG analysis and diagnosis of patients in these institutions; 2 Emancipate the labor force of professional ECG doctors in large hospitals, improve work efficiency, improve the level of diagnosis, and meet the rigid needs of related medical services; 3 ECG monitoring into the family, so that patients at home like monitoring blood pressure, blood sugar ECG monitoring; 4 The level of ECG analysis and diagnosis of wearable devices has been raised to the level of professional doctors, so that wearable devices (watches, bracelets, etc.) can truly provide medical level data, monitor the ECG status of patients, and make wearable devices more widely used Jeni turtle